TriangleNCT03576131 · MORE INFO
Limitations, agreements, and source contact
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- certain Agreement
- other Details
- The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is at least 12 months but less than 18 months from the end of study (database lock).The sponsor cannot require changes to the communication and cannot extend the embargo.
- pi Sponsor Employee
- false
- restriction Type
- OTHER
- restrictive Agreement
- true
- limitations And Caveats
- description
- Results of the biweekly dosing regimens are based on the Clinical Study Report.
- point Of Contact
- clinicaltrials@genmab.com
- organization
- Genmab
- phone
- +45 7020 2728
- title
- Clinical Trial Information
Complete source fields
- certain Agreement
- other Details
- The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is at least 12 months but less than 18 months from the end of study (database lock).The sponsor cannot require changes to the communication and cannot extend the embargo.
- pi Sponsor Employee
- false
- restriction Type
- OTHER
- restrictive Agreement
- true
- limitations And Caveats
- description
- Results of the biweekly dosing regimens are based on the Clinical Study Report.
- point Of Contact
- clinicaltrials@genmab.com
- organization
- Genmab
- phone
- +45 7020 2728
- title
- Clinical Trial Information
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice